Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Antibody System is a biotechnology company headquartered in France that specializes in the development and supply of high-quality antibodies and related reagents for life science research and diagnostic applications. The company offers an extensive catalog of products, including monoclonal antibodies, recombinant proteins, and ELISA kits, with a particular focus on therapeutic antibody research and biosimilar development. Their portfolio covers a wide range of research areas such as oncology, immunology, and infectious diseases, providing tools for researchers to study critical pathways like PD-1/PD-L1 and various cytokines. Antibody System serves a global customer base across academia, biotechnology, and pharmaceutical industries, supporting both basic research and drug discovery efforts.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Antibody System.